The study by Max Healthcare aims to collect seroepidemiological data from 10,000 healthcare workers employed at various facilities owned by Max Healthcare and Radiant Lifecare, and study the effectiveness of HCQ as prophylaxis for coronavirus infection, Max hospital group said in a statement.
There is no shortage of Hydroxychloroquine in India, informed Viranchi Shah, Chairman, Indian Drug Manufacturers’ Association, Gujarat chapter on Friday. However, the health ministry in an advisory earlier warned against the use of the drug without it being prescribed by a doctor for treating coronavirus.
Hydroxychloroquine, an anti-malarial drug termed potential "game changer" for COVID-19 by US President Donald Trump, showed no benefit in treating patients with the disease in Veterans Health Administration medical centres in the US, says a study.
The plan to use much touted anti-malarial drug hydroxychloroquine for treating COVID-19 patients has received a setback with more deaths being reported among those who were given the drug, according to a report.
In view of surge in the demand for anti-malarial drug Hydroxychloroquine (HCQ) amidst the coronavirus pandemic, pharmaceutical companies in Gujarat have stepped up efforts to ramp up its production for domestic as well as global markets, a senior official said on Sunday.
The health ministry has issued an advisory for the general public on the use of Hydroxychloroquine and other medicines asking citizens not to consume any medicine without being prescribed by a doctor.
India will provide hydroxychloroquine, which is being seen as a drug that may counter coronavirus, to over 50 countries while deliberations are underway on more such proposals.
o treat people infected with the coronavirus (COVID-19), many, including the US President Donald Trump, have supported the use of the anti-malarial drug hydroxychloroquine (HCQ).
As coronavirus outbreak spreads across Pakistan, Imran Khan government has sought India's help in curbing the virus. As per sources, Pakistan has asked India for Hydroxychloroquine to combat symptoms of coronavirus.
Coronavirus in Gujarat: Chief Minister Vijay Rupani recently said three companies from the state have been asked to produce hydroxychloroquine to export it to the US, after President Trump asked the Indian government for its supply.
Central government has approved release of Hydroxychloroquine (HCQ) for 13 countries.
Director of Delhi AIIMS Randeep Guleria said that taking Hydroxychloroquine (HCQ) can be harmful if taken without any prescription by a medical practitioner.
After President Donald Trump demanded the supply of Hydroxychloroquine to the US, a consignment of Hydroxychloroquine from India arrived at Newark airport on Sunday.
India has cleared a list of 13 countries for exporting of hydroxychloroquine, which is being seen as a drug that may counter coronavirus. News agency ANI said the listed countries included USA, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Afghanistan, Maldives, Bangladesh, Seychelles, Mauritius and Dominican Republic .
The drugs chloroquine, hydroxychloroquine and azithromycin, being used to treat and prevent COVID-19 despite weak evidence for their effectiveness, may have adverse side effects on patients like irregular heartbeats and reduced blood glucose levels, a new study says.
US President Donald Trump on Wednesday took to Twitter and thanked India for Prime Minister Narendra Modi's decision to allow the export of malaria drug Hydroxychloroquine to the US
Drug firm Zydus Cadila on Tuesday said it has received final nod from the US health regulator to market generic Perphenazine tablets used for the treatment of schizophrenia. The company has received final approval from the United States Food and Drug Administration (USFDA) to market Perphenazine tablets USP in the strengths of 2 mg, 4 mg, 8 mg and 16 mg, Zydus Cadila said in a statement.
The US Food and Drug Administration has given temporary approval of hydroxychloroquine drug in the treatment of COVID-19 patients. It is being experimented on more than 1,500 coronavirus patients in New York.
Rajasthan government on Tuesday decided to return 25 per cent of hydroxychloroquine tablets that it had acquired from distributors, stockists and others in the wake of the requirement of the drug for the management of coronavirus cases, an official said in Jaipur.
AIIMS on Tuesday said that all of its staff involved in treating coronavirus patients could ask for hydroxychloroquine tablets from their respective departments
Top News
Latest News
